XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Schedule of Revenue Recognized in Unaudited Condensed Consolidated Interim Statements of Profit or Loss (Detail) - EUR (€)
€ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue from external customers    
Sale of commercial products € 66,499 € 31,551
Rendering of services 4,624 1,170
Sale of clinical supply 1 254
Licenses 24,770 614
Total revenue 95,894 33,589
Revenue from external customers (geographical)    
Total revenue 95,894 33,589
Goods or services transferred over time [member]    
Revenue from external customers    
Total revenue 4,624 1,170
Revenue from external customers (geographical)    
Total revenue 4,624 1,170
Goods or services transferred at point in time [member]    
Revenue from external customers    
Total revenue 91,270 32,419
Revenue from external customers (geographical)    
Total revenue 91,270 32,419
Commercial customers [Member]    
Revenue from external customers    
Total revenue 66,499 31,551
Revenue from external customers (geographical)    
Total revenue 66,499 31,551
Collaboration partners and license agreements [Member]    
Revenue from external customers    
Total revenue 29,395 2,038
Revenue from external customers (geographical)    
Total revenue 29,395 2,038
Europe [Member]    
Revenue from external customers    
Total revenue 1,567  
Revenue from external customers (geographical)    
Total revenue 1,567  
North America [member]    
Revenue from external customers    
Total revenue 92,681 33,070
Revenue from external customers (geographical)    
Total revenue 92,681 33,070
Asia [Member]    
Revenue from external customers    
Total revenue 1,646 519
Revenue from external customers (geographical)    
Total revenue € 1,646 € 519